Merck & Co. Net gains (losses) on investments increased by 273.0% to $373.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1303.2%, from -$31.00M to $373.00M. Over 2 years (FY 2021 to FY 2023), Net gains (losses) on investments shows a downward trend with a -58.1% CAGR.
An increase suggests successful investment performance, though it does not reflect operational cash generation.
This reflects the non-cash impact of changes in the fair value of equity investments or securities held by the company....
Varies based on the size of the company's corporate venture capital or treasury investment portfolio.
cf_gain_loss_on_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $280.00M | $683.00M | $403.00M | -$708.00M | -$284.00M | -$371.00M | -$56.00M | $450.00M | -$175.00M | -$33.00M | $98.00M | $143.00M | $56.00M | -$31.00M | $90.00M | $100.00M | $373.00M |
| QoQ Change | — | +143.9% | -41.0% | -275.7% | +59.9% | -30.6% | +84.9% | +903.6% | -138.9% | +81.1% | +397.0% | +45.9% | -60.8% | -155.4% | +390.3% | +11.1% | +273.0% |
| YoY Change | — | — | — | — | -201.4% | -154.3% | -113.9% | +163.6% | +38.4% | +91.1% | +275.0% | -68.2% | +132.0% | +6.1% | -37.1% | +78.6% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.